Home Table of Contents

§ 6224. Reflex Sympathetic Dystrophy Syndrome Education Program

Purdon's Pennsylvania Statutes and Consolidated StatutesTitle 35 P.S. Health and SafetyEffective: March 1, 2004

Purdon's Pennsylvania Statutes and Consolidated Statutes
Title 35 P.S. Health and Safety (Refs & Annos)
Chapter 31B. Reflex Sympathetic Dystrophy Syndrome Education Act
Effective: March 1, 2004
35 P.S. § 6224
§ 6224. Reflex Sympathetic Dystrophy Syndrome Education Program
Currentness
(a) Establishment.--The department shall establish the Reflex Sympathetic Dystrophy Syndrome Education Program to promote public awareness of the causes of RSDS and the value of early detection, diagnosis and treatment of this disease.
(b) Duties of department.--The department shall:
(1) Establish a public education and outreach campaign via written materials and brochures to promote awareness of RSDS and enable individuals to make informed decisions about their health, including, but not limited to:
(i) Cause and nature of the disease.
(ii) Risk factors that contribute to the manifestation of the disease.
(iii) All available treatment options, including risks and benefits of said options.
(iv) Environmental safety and injury prevention.
(v) Rest and use of appropriate body mechanics.
(vi) Availability of RSDS diagnostic, treatment and outreach services in the community.
(vii) Any other factors or elements that might mitigate the effects of this disease.
(2) Develop educational materials and brochures which shall be made available to consumers through State and local departments of health, hospitals, clinics and other health care providers.
(3) Develop relationships with health care providers and health-related community-based organizations to promote and coordinate professional education programs on RSDS for, including, but not limited to:
(i) Research findings.
(ii) Cause and nature of the disease.
(iii) Risk factors, including, but not limited to, lifestyle, heredity and drug interactions.
(iv) Diagnostic procedures and appropriate indications for their use.
(v) All medical and surgical treatment options, including experimental and established drug therapies and the benefits and risks of each option.
(vi) Environmental safety and injury prevention.
(vii) Availability of RSDS diagnosis, treatment and support services in the community.

Credits

2003, Dec. 30, P.L. 434, No. 62, § 3, effective March 1, 2004.
35 P.S. § 6224, PA ST 35 P.S. § 6224
Current through Act 10 of the 2024 Regular Session. Some statute sections may be more current, see credits for details.
End of Document